With Thursday's IPO pricings from Adaptive Biotechnologies Corp., Bridgebio Pharma and Morphic Holding Co., 2019 swallowed last year's record for the most money ever raised through biopharma IPOs in the month of June, bringing in $1.97 billion compared with $1.64 billion last year.